Citarabina y reacciones cutáneas en leucemia aguda mieloide. / [Cytarabine and skin reactions in acute myeloid leukemia].
Medicina (B Aires)
; 73(6): 535-8, 2013.
Artigo
em Espanhol
| BINACIS
| ID: bin-132783
ABSTRACT
Cytarabine is an antimetabolite used in the treatment of acute myeloid leukemia (AML). It has many adverse effects as myelosuppression, toxic reactions involving central nervous system, liver, gastrointestinal tract, eyes or skin. Dermatologic toxicity is often described as rare; nevertheless there are differences in the reported frequency. We performed a retrospective study including all AML treated with chemotherapy that involved cytarabine between 1st July of 2006 and 1st July of 2012; 46 patients were included with a median age of 55 years. The overall incidence of skin reactions was 39
Buscar no Google
Coleções:
Bases de dados nacionais
/
Argentina
Base de dados:
BINACIS
Assunto principal:
Leucemia Mieloide Aguda
/
Erupção por Droga
/
Citarabina
/
Antimetabólitos Antineoplásicos
Tipo de estudo:
Estudo de etiologia
/
Estudo de incidência
/
Estudo observacional
/
Estudo prognóstico
/
Fatores de risco
Aspecto:
Preferência do paciente
Limite:
Idoso, 80 anos ou mais
Idioma:
Espanhol
Revista:
Medicina (B Aires)
Ano de publicação:
2013
Tipo de documento:
Artigo